Document is current
Any future updates will be listed below
-
Authors
Orina, Fred
Hikone, Mayu
Saito, Nobuo
Ong’ang’o, Jane
Nyerere, Andrew
Songoro, Edinah
Meme, Helen
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (24jk0110031h0001)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 27 June 2025
First Online: 1 July 2025
Declarations
:
: The study protocol, including the follow-up and assessment of LAM levels using the PATHFAST TB LAM Ag assay, was reviewed and approved by the KEMRI-SERU (Ethical Approval Number: SERU 4595). All participants provided written informed consent prior to enrollment, including consent for serial sputum collection throughout the follow-up period.
: Not applicable.
: The authors declare no competing interests.
